<?xml version="1.0" encoding="UTF-8"?>
<abstract abstract-type="author-highlights" id="abs0005">
 <title>Highlights</title>
 <p>
  <list list-type="simple" id="lis0005">
   <list-item id="lsti0005">
    <label>•</label>
    <p id="par0005">CCR5 regulates multiple cell types (
     <italic>e.g.</italic>, T regulatory and Natural Killer cells) and immune responses.
    </p>
   </list-item>
   <list-item id="lsti0010">
    <label>•</label>
    <p id="par0010">The effects of CCR5, CCR5Δ32 (variant associated with reduced CCR5 expression) and CCR5 antagonists vary between infections.</p>
   </list-item>
   <list-item id="lsti0015">
    <label>•</label>
    <p id="par0015">CCR5 affects the pathogenesis of flaviviruses, especially in the brain.</p>
   </list-item>
   <list-item id="lsti0020">
    <label>•</label>
    <p id="par0020">The genetic variant CCR5Δ32 increases the risk of symptomatic West Nile virus infection.</p>
   </list-item>
   <list-item id="lsti0025">
    <label>•</label>
    <p id="par0025">The triad “CCR5, extracellular vesicles and infections” is an emerging topic.</p>
   </list-item>
  </list>
 </p>
</abstract>
